©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16079-16094
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16079
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16079
Table 5 Studies conducted on humans showing effects of prebiotics on metabolic disorders
| Studied subject | Prebiotic | Duration of treatment | Effects | Ref. |
| Healthy men and women | OFS | 2 wk | ↓Food and energy intake, hunger | [132] |
| ↑satiety | ||||
| Healthy humans | GOS | 12 wk | Significant ↑Bifidobacterium | [133] |
| Obese women | Inulin-type fructans | 3 mo | ↑Bifidobacterium and Faecalibacterium prausnitzii | [134] |
| ↓Circulating LPS, Bacteroides, Propionibacterium | ||||
| Obese-dyslipidemic women | Yacon syrup (containing OFS) | 120 d | ↓Body weight, BMI, waist circumference, serum LDL cholesterol levels | [135] |
| Overweight and obese adults | OFS | 12 wk | ↓Body weight, ghrelin, calories intake, serum glucose, insulin | [136] |
| ↑peptide YY |
- Citation: Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20(43): 16079-16094
- URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16079.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16079